Production (Stage)
LeMaitre Vascular, Inc.
LMAT
$81.40
$2.282.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.19% | 13.63% | 14.81% | 16.06% | 18.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.19% | 13.63% | 14.81% | 16.06% | 18.16% |
| Cost of Revenue | 5.29% | 3.80% | 2.64% | 5.28% | 12.99% |
| Gross Profit | 17.18% | 18.77% | 21.48% | 22.02% | 20.96% |
| SG&A Expenses | 16.37% | 13.87% | 14.16% | 13.08% | 14.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.96% | 7.24% | 7.80% | 9.39% | 14.40% |
| Operating Income | 29.63% | 40.48% | 46.09% | 47.57% | 35.46% |
| Income Before Tax | 31.78% | 44.08% | 50.63% | 53.16% | 60.86% |
| Income Tax Expenses | 27.70% | 37.00% | 47.80% | 66.58% | 49.91% |
| Earnings from Continuing Operations | 33.02% | 46.28% | 51.53% | 49.40% | 64.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.02% | 46.28% | 51.53% | 49.40% | 64.51% |
| EBIT | 29.63% | 40.48% | 46.09% | 47.57% | 35.46% |
| EBITDA | 24.60% | 32.57% | 36.76% | 37.35% | 27.38% |
| EPS Basic | 31.73% | 44.77% | 49.91% | 47.67% | 62.61% |
| Normalized Basic EPS | 29.98% | 40.86% | 47.02% | 49.17% | 42.00% |
| EPS Diluted | 31.41% | 45.20% | 50.42% | 47.14% | 61.61% |
| Normalized Diluted EPS | 29.26% | 40.21% | 46.72% | 49.12% | 41.90% |
| Average Basic Shares Outstanding | 1.00% | 1.06% | 1.09% | 1.17% | 1.18% |
| Average Diluted Shares Outstanding | 1.56% | 1.53% | 1.28% | 1.18% | 1.24% |
| Dividend Per Share | 17.24% | 14.29% | 13.76% | 13.21% | 12.62% |
| Payout Ratio | -0.11% | -0.21% | -0.24% | -0.23% | -0.31% |